News & Updates from McGivney Global

McGivney Global

Sep 29, 20201 min read

Executive Order Would Tie U.S. Drug Prices to What Other Countries Pay

Read Bill McGivney's editorial comment in OBR regarding an executive order aiming to address high prescription drug prices:...

McGivney Global

Sep 19, 20190 min read

New McGA Program: Oncology Specialty Pharmacy Workshop

McGivney Global

Oct 11, 20181 min read

Collaboration with McGA achieves NCCN Preferred positioning

McGivney Global

Aug 24, 20183 min read

CMS Allows MA Plans to Apply Step Therapy to Part B Drugs in 2019

By Jon Larsen, JD, MPP, McGA Policy Consultant In August 2018, the Centers for Medicare and Medicaid Services (CMS) rescinded 2012...

McGivney Global

Jun 29, 20182 min read

Operational Implementation of CAR-T Cell Therapy

McGivney Global

Jun 21, 20182 min read

Webinar: What Biotech and Pharma execs need to know about blockchain

McGivney Global

May 24, 20181 min read

Free Webinar: Is CAP Coming Back?

McGivney Global

May 24, 20182 min read

40 Under 40 in Cancer: Congratulations Awardees!

McGivney Global

Apr 3, 20182 min read

MedPAC, MIPS, and the Tenacity of Fee-for-Service

McGivney Global

Feb 15, 20182 min read

RE: Alphabet-Backed Flatiron Health is Being Acquired by Roche

McGivney Global

Oct 5, 20173 min read

More NCCN Categories Bring Inconsistency, Uncertainty, and Consternation

McGivney Global

Oct 25, 20161 min read

Oncologists, McGivney Weigh in on Value Frameworks

McGivney Global

Oct 25, 20162 min read

Comments on the Recent Institute for Clinical and Economic Review (ICER) Meeting

McGivney Global

Jul 11, 20161 min read

Impact of Oncology Value Metrics

McGivney Global

Jul 8, 20164 min read

Health Insurers Behaving Badly...

McGivney Global

Jun 28, 20166 min read

Life, Death, and Money: The Hidden Economics of Cancer

McGivney Global

Jun 16, 20161 min read

McGA work on ICER cited by BIO

McGivney Global

Apr 18, 20162 min read

RE: ICER to Evaluate Value of Amgen's Multiple Myeloma Treatment

McGivney Global

Mar 16, 20165 min read

McGIVNEY

GLOBAL

ADVISORS

News & Updates from McGivney Global

Executive Order Would Tie U.S. Drug Prices to What Other Countries Pay

New McGA Program: Oncology Specialty Pharmacy Workshop

Collaboration with McGA achieves NCCN Preferred positioning

CMS Allows MA Plans to Apply Step Therapy to Part B Drugs in 2019

Operational Implementation of CAR-T Cell Therapy

Webinar: What Biotech and Pharma execs need to know about blockchain

Free Webinar: Is CAP Coming Back?

40 Under 40 in Cancer: Congratulations Awardees!

MedPAC, MIPS, and the Tenacity of Fee-for-Service

RE: Alphabet-Backed Flatiron Health is Being Acquired by Roche

More NCCN Categories Bring Inconsistency, Uncertainty, and Consternation

Oncologists, McGivney Weigh in on Value Frameworks

Comments on the Recent Institute for Clinical and Economic Review (ICER) Meeting

Impact of Oncology Value Metrics

Health Insurers Behaving Badly...

Life, Death, and Money: The Hidden Economics of Cancer

McGA work on ICER cited by BIO

RE: ICER to Evaluate Value of Amgen's Multiple Myeloma Treatment

How Medicare is Gambling with Cancer Care